Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
12/29/2004 | EP1194137B1 Naphthoquinone derivatives and their use in the treatment and control of tuberculosis |
12/29/2004 | EP1177178B1 Heterocyclically substituted benzimidazoles, the production and application thereof |
12/29/2004 | EP1124576B1 Method for preparing solid phase conjugate vaccines |
12/29/2004 | EP1090033B1 Particles of hcv envelope proteins: use for vaccination |
12/29/2004 | EP1084251B1 Attenuated pestiviruses |
12/29/2004 | EP1011720B1 Mucosal cytotoxic t lymphocyte responses |
12/29/2004 | EP0830130B9 Tnf-alpha converting enzyme |
12/29/2004 | EP0725792B1 PROCESS FOR PRODUCING RECOMBINANT PilC PROTEINS |
12/29/2004 | EP0725635B1 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
12/29/2004 | EP0626008B1 Vaccine containing acemannan as an adjuvant |
12/29/2004 | EP0623172B1 Marek's disease virus recombinant vaccinia virus vaccine |
12/29/2004 | CN1558950A Somatic cell derived embryonic stem cell and its differentiated cell |
12/29/2004 | CN1558903A Water-soluble phenylpyridazine compounds and compositions containing the same |
12/29/2004 | CN1558898A Antiviral agent |
12/29/2004 | CN1558895A Compositions for treating acne comprising phytandiol amine |
12/29/2004 | CN1558773A Conjugate vaccine composed of the polysaccharide moiety of the lipopolysaccharide of vibrio cholerae O139 bound to tetanus toxoid |
12/29/2004 | CN1558771A Method for treating hepatitis c virus infection in treatment failure patients |
12/29/2004 | CN1558767A A pharmaceutical composition made from Chinese traditional medicine for treating snuffle, headache and preparation method thereof |
12/29/2004 | CN1558763A Treatment of hepatitis B virus infection with human monoclonal antibodies |
12/29/2004 | CN1558760A Photodynamic porphyrin antimicrobial agents |
12/29/2004 | CN1558759A 病毒聚合酶抑制剂 Viral polymerase inhibitors |
12/29/2004 | CN1557837A Process for preparing multi-bioactive substances from cattle colostrum |
12/29/2004 | CN1557824A Silkworm excrement total alkaloid and its preparation method |
12/29/2004 | CN1557812A Potassium sodium dehydroandroandrographolide succinates and their preparations |
12/29/2004 | CN1557808A 3-substituted piperazine triadimenol antifungal compounds and their salts |
12/29/2004 | CN1557494A Preparation of microorganism resisting biological active component and its application |
12/29/2004 | CN1557490A Microorganism infection resisting immune globulin |
12/29/2004 | CN1557489A Preparation of oral administered immune globulin from whey |
12/29/2004 | CN1557486A Bivalent DNA vaccine of type A and type O foot-and-mouth disease virus and its preparing process |
12/29/2004 | CN1557485A Application of gene recombined human lysozyme in eliminating pathogenic microorganism infection |
12/29/2004 | CN1557465A Spleen aminopeptide preparation and its preparing method |
12/29/2004 | CN1557464A 转移因子片剂 Transfer Factor Tablets |
12/29/2004 | CN1557460A Tuber culosis treating Chinese medicine |
12/29/2004 | CN1557447A Preparation of detoxification tablet |
12/29/2004 | CN1557442A Liniment for skin and its preparation |
12/29/2004 | CN1557411A Soft capsule of wintersweet leaf and its preparing method |
12/29/2004 | CN1557408A Medicinal composition for treating common and infectious cold |
12/29/2004 | CN1557396A Chinese medicinal composition for treating hepatitis B |
12/29/2004 | CN1557389A Preparing process of cold treating ageratum and chrysanthemum soft capsule |
12/29/2004 | CN1557387A Aromatic turmeric oil extracts and its preparing process and medicinal composition containing the same |
12/29/2004 | CN1557369A Medicine for preventing and treating infectious coryza |
12/29/2004 | CN1557368A Medicine for preventing and treating fowl pos disease |
12/29/2004 | CN1557354A Chinese medicine aqueous pill preparation for treating hepatitis B and its preparation process |
12/29/2004 | CN1557333A Chinese traditional medicine composition and its preparation and quality control method thereof |
12/29/2004 | CN1557330A Sustained release medication of clindamycinum |
12/29/2004 | CN1557327A Adefovir dipivoxil and polyethylene glycol fused matter and its preparation method |
12/29/2004 | CN1557322A Use of diazocine analogue in preparation of antineoplastic and antifungal medicine |
12/29/2004 | CN1557321A Cefuroxime, beta-lactamase inhibitor containing composition |
12/29/2004 | CN1557317A Enoxacin Glyconate little volume injection and its preparation method |
12/29/2004 | CN1557316A Enoxacin Glyconate large volume injection and its preparation method |
12/29/2004 | CN1557315A Baloxin water-soluble salt and its injection formulation |
12/29/2004 | CN1557314A Prulifloxacin water-soluble salt and its injection formulation |
12/29/2004 | CN1557311A Fibrauretine capsule tablet and its preparation method |
12/29/2004 | CN1557306A Flavescent sophora root essence dispersion tablet |
12/29/2004 | CN1557305A Matrine drop pills and its preparation method |
12/29/2004 | CN1557303A Use of Pidotimod in preparation of hepatitis B treating medicine |
12/29/2004 | CN1182143C Bis-(N,N'-bis-(2-haloethyl) amino) phosphoramidates as antitumor agents |
12/29/2004 | CN1182139C Process for preparing a pure, pharmacopoeial grade amorphous form of cefuroxime axetil |
12/29/2004 | CN1182138C Process for preparing crystalline salts of amoxycillin |
12/29/2004 | CN1182137C Preparation method and use of sodium Penciclovir sodium hydrate |
12/29/2004 | CN1182134C Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for treatment of pain |
12/29/2004 | CN1182116C Mutilin derivatives and their use as antibacterials |
12/29/2004 | CN1182114C Piperazine derivatives used as CCR5 antagonist |
12/29/2004 | CN1181890C Use of enterobacterium protein OmpA in the preparation of antigen presentation cells specified targeting medicine |
12/29/2004 | CN1181888C Stable recombination human alpha interferon liquid preparation and productive process thereof |
12/29/2004 | CN1181883C Application of cymose buckwheat rhizome in preparation of antiviral drug |
12/29/2004 | CN1181873C Medicine for treating summer dampness cold and its preparing method |
12/29/2004 | CN1181872C Medicine for treating acute pulmonary infection disease and its preparing method |
12/29/2004 | CN1181855C Preparing method of hypericum perforatum extract |
12/29/2004 | CN1181848C Syphilis treating Chinese medicine |
12/29/2004 | CN1181846C Traditional Chinese medicine for treating child pneumonia |
12/29/2004 | CN1181842C Aseptic necrosis of head of femur treating traditional Chinese medicine pills |
12/29/2004 | CN1181834C Medicine for treating pyoderma and its preparing process |
12/29/2004 | CN1181832C Preparation of AIDS resisting medicine from indian stringbush root extract |
12/29/2004 | CN1181824C Minocycline vaginal effervescent tablets |
12/29/2004 | CN1181823C Use of L-threonic acid as active adjuvant of quinolone medicine |
12/29/2004 | CN1181820C Process for preparing miconazole nitrate ointment |
12/29/2004 | CN1181818C Method for treating protozoal infections |
12/29/2004 | CN1181738C Therapeutic anti-fungal nail preparation |
12/29/2004 | CA2530004A1 Agent for inhibiting membrane virus reproduction, method for the production thereof, pharmaceutical composition and method for inhibiting viral infections |
12/29/2004 | CA2529955A1 Microbicidal, prophylactic and therapeutic effect of ctc-96 on papilloma viruses |
12/29/2004 | CA2529949A1 Antiviral compounds and methods |
12/29/2004 | CA2529847A1 Antiviral compositions and methods of using the same |
12/29/2004 | CA2529565A1 Modified bordetella adenylate cyclase comprising or lacking cd11b/cd18 interaction domain and uses thereof |
12/29/2004 | CA2529287A1 Method for inhibiting the growth of antibiotic-resistant of bacteria by using pentane-1,5-diol |
12/29/2004 | CA2529268A1 Pharmaceutical formulations of amyloid inhibiting compounds |
12/28/2004 | US6835837 Antiallergens; antiinflammatory agents; skin disorders; osteoporosis |
12/28/2004 | US6835829 Purification process |
12/28/2004 | US6835826 Acid resistance, stability; telomerase inhibitor |
12/28/2004 | US6835818 Mutants of Streptococcal toxin C and methods of use |
12/28/2004 | US6835755 Naphthoquinone derivatives and their use in the treatment and control of tuberculosis |
12/28/2004 | US6835753 Administering to the patient for inhibiting Fc receptor binding of immunoglobulin a compound selected from aromatic, heteroaromatic, cyclic, bicyclic and an amino acid derivative or salt |
12/28/2004 | US6835749 Sulfohydroxamic acids and sulfohydroxamates and their use as MEK inhibitors |
12/28/2004 | US6835731 Chemokine receptor binding heterocyclic compounds |
12/28/2004 | US6835726 For therapy of viral infections, particularly human Cytomegalovirus infection |
12/28/2004 | US6835716 Bactericides, antiprotozoa agents |
12/28/2004 | US6835711 Use of poly-Glu,Tyr for neuroprotective therapy |
12/28/2004 | US6835546 Drosophila G protein coupled receptors, nucleic acids, and methods related to the same |
12/28/2004 | US6835536 Therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, in the treatment of microorganism-caused infections, which infections may be systemic, such as a |
12/28/2004 | US6835372 Mixtures of di-(tri)peptides and drugs such as cyclosporin used as aerosols; drug delivery |